Showing results (51-60 of 609) with videos related to
Sort By:
Pageof 61
Urology|December 3, 2014
Extent of extraprostatic extension independently influences biochemical recurrence-free survival: evidence for further pT3 subclassificationMark W Ball, Alan W Partin, Jonathan I EpsteinUrology|September 6, 2005
Kinetics of tumor growth of prostate carcinoma estimated using prostate-specific antigenAlexander M Truskinovsky, Alan W Partin, Martin H KrollCancer|March 29, 2002
Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomyGanesh V Raj, Alan W Partin, Thomas J PolascikThe Journal of Urology|June 4, 2013
Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancerStacy Loeb, Anders Berglund, Pär StattinCurrent Opinion in Urology|June 5, 2016
Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancerStacy Loeb, Hans Lilja, Andrew VickersCancer|September 5, 2002
Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinomaAlexander Haese, Jonathan I Epstein, Hartwig Huland, et al.The Urologic Clinics of North America|November 29, 2015
The Prostate Health Index: Its Utility in Prostate Cancer DetectionAbbey Lepor, William J Catalona, Stacy LoebEuropean Urology|March 15, 2015
Future-proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?Stacy Loeb, Francesco Montorsi, James W CattoAnnals of Internal Medicine|March 22, 2006
Viewpoint: expanding prostate cancer screeningWilliam J Catalona, Stacy Loeb, Misop HanEuropean Urology|July 14, 2023
The Plant-based Prescription: How Dietary Change Can Improve Both Urological and Planetary HealthAlexander P Cole, Natasha Gupta, Stacy LoebPageof 61